Pandion Operations, Inc.

Pandion Therapeutics, Inc.

Seismic Therapeutic, Inc.

Biogen Ma Inc.

Pandion Operation, Inc.

Sunesis Pharmaceuticals, Inc.

Kevin Lewis Otipoby

Joanne Louise Viney

Nathan Higginson-Scott

Erik Robert Sampson

Jyothsna Visweswaraiah

Nathan Higginson-scott

Yanfeng Zhou

Lindsay J Edwards

Salvatore Alioto

Ryan Peckner

Gnanasambandam Kumaravel

Bin Ma

Brian T Hopkins

Timothy Raymond Chan

Jacob Glanville

Hua Miao

Yi Xing

Alex Pellerin

Nathan Rollins

Ivan Mascanfroni

Jordan Anderson

Sarah Ives

Andrea Bertolotti-Ciarlet

Christina Pettus

Daniel Rios

Susmita Borthakur

Purvi Mande

Daniela Cipolletta

David Maurer

Yen-Lin Chen

Lauren Schwimmer

The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.

IL-2 muteins and uses thereof

Embodiments provided herein, provide for polypeptides and molecules comprising a polypeptide having protease activity and a variant Fc molecule, pharmaceutical compositions comprising the same, and methods that can be used to treat disorders, such as IgG mediated disorders.

Protease variants and uses thereof

Embodiments provided herein, provide for variant IgG Fc polypeptides, dimeric molecules, pharmaceutical compositions, and methods that can be used to target at cells to modulate the activity of the same to treat disorders, such as autoimmune disorders or cancers.

Variant IgG Fc polypeptides and uses thereof

Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.

Tissue targeted immunotolerance with a CD39 effector

Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.

MAdCAM targeted immunotolerance

The present invention provides compounds and compositions thereof which are useful as inhibitors of Bruton's tyrosine kinase and which exhibit desirable characteristics for the same.

Biaryl bruton's tyrosine kinase inhibitors

IL-2 muteins

Growing community of inventors

Cambridge, MA, United States of America

Kevin Lewis Otipoby